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Acquired resistance  to infection with intracellular  bacterial parasites  has its 
origin in an immunological mechanism in which specifically committed lymph- 
oid cells have a  crucial role (1).  Cells with the capacity to protect normal mice 
(2)  and normal rats  (3)  against infection with Listeria monocytogenes  appear in 
the spleen and thoracic duct early in the course of a primary Listeria infection. 
The failure  of the protective cells  to adhere  to glass or cotton,  their  presence 
in central lymph, and suppression by anti-lymphocyte globulin (4)  imply that 
antimicrobial resistance  is transmitted  by a  species of lymphocyte. 
Although nearly all the cells in rat thoracic duct lymph qualify as lympho- 
cytes, they vary with respect to size and structure,  turnover, and possibly with 
respect to origin and immunological  capacity  (5,  6).  The  present  radioauto- 
graphic study was designed to measure the labeling characteristics and circula- 
tion dynamics of the cells which afford protection  against  a  systemic Listeria 
infection. The results indicate that cells with this commission belong to a  lym- 
phocyte  population  that  has  a  rapid  turnover  and  a  short-circulating  life- 
span. 
Materials and Methods 
Animals.--The  experimental subjects were male and female Lewis rats and members of the 
F1 hybrid cross between these and rats of the DA strain. Donors of thoracic duct cells weighed 
160-250 g; the recipients, in whom antimicrobial resistance was assayed, weighted 60-110 g. 
Microorganisms.--Listeria monocytogenes, strain EGD, has been maintained  by continuous 
passage in mice for the past 2 yr. Suspensions for immunization  or challenge were prepared 
from 16 hr trypticase  soy broth cultures of infected spleen. 
Immunization.--Prospecfive  donors  of thoracic  duct  cells were  specifically immunized 
against L. monocytogenes  with living organisms injected subcutaneously into both hind footpads 
and over the lower abdomen. The total injection volume was 0.5 ml; it contained  approxi- 
mately 5 X  l0  G  viable units. 
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Diseases, and Grant T499 from the American Cancer Society. 
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Measurement of Protective Immunity.--Protection  against a challenge infection was meas- 
ured in terms of the numbers of viable bacteria present in the liver and spleen at intervals after 
an intravenous injection of approximately 107 viable L. monocytogenes.  The initial implantation 
of the challenge organism was obtained by plating homogenates of livers and spleens from four 
rats, sacrificed  1 hr after injection. Its subsequent behavior was determined in groups of four 
to six rats sacrificed 24, 48, and sometimes 72 hr after challenge. 
Preparation of Lymphocytes.--Thoracic duct lymph was collected on the 7th day of a pri- 
mary immunizing infection. The lymph from freshly cannulated donors was collected at 4°C 
into sterile flasks containing 5 ml of Ringer's solution, 100 units of heparin, and 60 #g of peni- 
cillin. Collections of 18-24 hr duration were obtained from several animals. These were pooled, 
filtered through surgical gauze to remove fibrin clots, and centrifuged for 10 mill at 500 g. 
After washing once in tissue culture medium 199 (7) containing 1% fetal calf serum, the cells 
were resuspended in fresh medium at a suitable concentration for labeling or injection. 
In experiments involving the injection of radioactively labeled cells, individual recipients 
were housed in a restraining cage (8) and given a continuous femoral vein infusion of Ringer's 
solution containing the appropriate nonradioactive nucleoside,  delivered at the rate of 1.2 mg 
per day. The infusion began several hours before the injection of labeled cells and was con- 
tinued to the end of the experiment. 
Radioactive Labeling of Lymphocytes.--Thoracic  duct cells were labeled in their DNA by 
injecting the intact animal with tritiated thymidine (3H-thymidine, 3  Ci per mmole, New 
England Nuclear Corp.,Boston, Mass.).Inoneexperiment,  thoracicductcellswerelabeledalso 
in their RNA by incubating the cells in vitro with tritiated uridine (3H-5-uridine,  20 Ci per 
mmole, New England Nuclear Corp. The cells were suspended at a concentration of 5 >(  107 
cells per milliliter in medium 199 containing 5% fetal calf serum and 1 unit of heparin per 
milliliter.  3H-5-uridine  was added to give a final concentration of 2/zCi/ml and the mixture 
was incubated for 1 hr at 37°C in a water bath oscillating at 120 cpm. The cells were then 
washed once in nonradioactive medium and resuspended in fresh medium for injection. More 
than 95% of the cells prepared in this manner were viable,  as judged by their appearance in 
the counting chamber and their ability to exclude trypan blue. 
Enzyme Treatment.--Air-dried smears of lymphocytes were fixed for 10 min at 4°C in 90% 
v/v ethyl alcohol and 10% v/v glacial acetic acid. The cells were then treated for 1 hr at 37°C 
with the appropriate nucleases to remove RNA, DNA, or both. RNA was removed by incubat- 
ing the cells in 0.025  ~  sodium phosphate buffer, pH 7.5, containing 0.5 mg/ml of RNAse 
(ribonuclease A,  3100  units/mg, Worthington Biochemical Corp., Freehold, N.  J.);  DNA 
was extracted in 0.025 ~t sodium barbiturate buffer, pH 7.5, containing 0.003 ~  magnesium 
sulphate and 0.1 mg/ml of DNAse (deoxyribonuclease I, 2500 units/rag, Worthington Bio- 
chemical Corp.). After treatment, the smears were rinsed for at least 30 rain in running tap 
water. 
Radioautography.--Fixed smears of lymphocytes  were extracted for 20 rain at 4°C with two 
changes of 5/% trichloroacetic acid, then washed for at least 1 hr in cold running water. They 
were subsequently coated with a 2:1 dilution of K-5 nuclear research emulsion (Ilford Ltd., 
Ilford, Essex, England)  and were exposed for either 2 or 6 wk. The radioautographs were 
stained after development  with May-Griinwald-Giemsa  stain. 
RESULTS 
Protective  Capacity  of  Thoracic  Duct  Cells.--Thoracic  duct  cells  obtained 
from rats on the 7th day of either a local or systemic infection with L. mono- 
cytogenes  can protect normal recipients against a Listeria challenge (3).  In the 
experiment  recorded  in  Fig.  1,  two groups  of  cell  recipients  and  a  group  of D.  D.  McGR.EGOR~  ~'.  T.  KOSTER,  AND  G.  B.  MACKANESS  391 
normal controls  were challenged intravenously with 4.3  X  106  viable Listeria 
1 hr before the transfer of thoracic duct cells from a  panel of Listeria-infected 
donors. The cells were given intravenously in doses of 2  X  10  s or 5  X  l0  T per 
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FIG. 1.  Curves describing the growth of L. monocytogenes in the livers and spleens of normal 
rats (O  O)  and rats protected with either 5 X  105 (O  O) or 2 X  106  (/k  /k) 
thoracic duct cells per gram of body weight. The cells were obtained from syngeneic donors on 
the 7th day of a primary Listeria infection.  Means and ranges of five animals per time point. 
100 g body weight. Their protective effect was expressed immediately in both 
liver and spleen and was greater with the larger dose of cells. 
Production  of  Immunologically  Committed  Lymphocytes.--Cells  which  can 
protect normal rats against L. monocytogenes appear in the thoracic duct within 
1 wk of a primary Listeria infection. Since they are not normally present there, 
they must be part of a  cell population that is added to the lymph of infected 392  TIIE MEDIATOR  OF CELLULAR  NUNITY.  I 
animals. The delivery of newly formed lymphocytes to the thoracic duct was 
therefore studied by injecting 3H-thymidine (0.34 #Ci per gram of body weight) 
into normal and acutely infected animals every 8 hr for 6 days. The numbers 
of cells recovered from the two groups on the  7th day were comparable, but 
varied greatly from animal  to  animal,  mainly because  the  lymph flow from 
cannulated  rats  tends  to be irregular.  For  this  reason the  output  of labeled 
cells from normal and infected animals was not compared in absolute numbers. 
It is evident from Fig. 2, however, that the lymph of infected donors contained 
an increased percentage of radioactively labeled large and medium lymphocytes 
and  a  greatly increased  percentage  of labeled  small  lymphocytes. It is  pre- 
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FIG. 2.  Number of radioactively labeled lymphocytes in samples of 2000 cells distributed 
according to their grain counts. The subjects, three normal and three Listeria-infected rats, 
were injected repeatedly with 3H-thymidine (see text). The lymph from infected animals 
contained an increased percentage of labeled lymphocytes but the distribution of radioactivity 
in the two populations was similar. Radioautographs exposed 6 wk. 
sumably among  this  group  that  we  should  look for  the  cells  which  convey 
antimicrobial immunity. 
Comparison  of the Protection Afforded  by Cells from Thoracic Duct Lymph of 
Actively  and Adoptively  Immunized Donors.--If  the  lymph-borne cells  which 
can protect recipients belong to the pool of lymphocytes which recirculate from 
blood to lymph  (9),  it should  be possible to recover them from the  thoracic 
duct of an intermediate host.  Cells from the thoracic duct lymph of Listeria- 
infected donors  were  therefore injected intravenously into  a  panel of normal 
intermediate hosts.  Thoracic duct cells obtained from the inoculated  animals 
24-48 hr after injectior~  were tested for their ability to protect a second group 
of normal recipients  against  a  Listeria  challenge.  Table  I  indicates  that  the 
growth of L. monocytogenes was significantly inhibited in the livers and spleens 
of recipients given only 2  X  l0  T thoracic duct  cells from a  panel of actively 
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of  uninfected  animals  which  had  been  adoptively  immunized  with  5  )<  108 
cells  from the  same  donor source  failed  to  influence  a  Listeria  infection  in  a 
second panel of normal rats. 
The failure  of cells with  protective  properties  to reappear  in  the  lymph  of 
adoptively immunized animals suggested that lymphocytes with a  rapid turn- 
over do not recirculate.  This notion was tested in an experiment  which meas- 
ured the circulation dynamics and immunological performance  of newly formed 
lymphocytes,  including  those generated  during  an  immunizing infection.  The 
method exploited  the fact that thoracic duct cells can be labeled radioactively 
TABLE I 
Protective  Capacity  of  Thoracic  Duct  Cells from  Actively  Immunized  Donors  and  Adoptively 
Immunized Intermediate  Hosts 
Donor immunization  No. cells injected 
(IOG/IO0 g body wt) 
Logi0 protection* 
Liver  Spleen 
Active*  50  1.20  0.81 
20  0.94  0.72 
Adoptive§  200  --0.30  --0.01 
100  --0.58  --0.25 
50  --0.44  --0.17 
* Difference in viable Listeria  in tissue  of five normal rats and groups of five rats given 
thoracic duct cells. In each case approximately  48 hr elapsed between the collection of cells 
from infected donors and i.v. challenge of the recipients with 107 L. monocytogenes. Animals 
sacrificed 48 hr after challenge. Using Duncan's multiple  range test,  all means in recipients 
of cells from actively immunized donors were found to be significantly different from those 
given cells from adoptively immunized donors at the P  <  0.01 level. 
Infected with approximately 5 X  106 L. monocytogenes. Thoracic duct cannulated  on 7th 
day of immunizing infection. 
§ Injected i.v. with 5  X  l0  s thoracic  duct cells from actively immunized  donors.  Cells 
collected from thoracic duct 24-48 hr after injection.  ~! 
in both their I)NA and RNA. Lymphocytes generated during  the first 6  days 
of a primary Listeria  infection were labeled in their DNA by injecting the ani- 
mals  repeatedly  with  3H-thymidine;  those  formed  during  (and  before)  im- 
munization  were  labeled  in  their  RNA by incubating  the  in vitro with  3H-5- 
uridine  (Fig. 3). 
The injection schedule employed in this experiment (Table II) resulted in the 
radioactive labeling of nearly all the large and medium lymphocytes and 16.4 % 
of  the  small  lymphocytes;  after  incubation  with  8H-5-uridine,  84.6%  of  the 
small  lymphocytes  were  labeled.  The  specificity  of  the  label  for  DNA  and 
RNA was confirmed by treating the cells with DNAse and RNAse, respectively. 
Cells double-labeled in this manner were washed and injected intravenously 
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tive material,  each  recipient was  given a  continuous  intravenous  infusion  of 
Ringer's  solution  containing  nonradioactive  thymidine  and  nonradioactive 
uridine which wa:s delivered at the rate of 1.2 mg per day (10,  11). Radioauto- 
graphs prepared from the recipients' thoracic duct cells, collected over the 24 
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FIO. 3.  Schematic diagram of experiment in which thoracic duct cell,s formed during and 
before a primary Listeria infection were compared with respect to their circulation dynamics 
and ability to transmit antimicrobial resistance  through an intermediate host (see text). 
TABLE II 
Circulation Dynamics of Thoracic Duct Cells  from Listeria-Infected Donors 
Per cent lymphocytes labeled 
Thoracic duct cells  Large and medium*  Small* 
Labeled small 
lymphocytes 
(RNA/DNA) 
DNA  RNA  DNA  RNA 
Donors:~  98.5  > 99.5  16.4  84.6  5.15 
Recipients  §  < 0.5  0.5  1.1  20.3  18.45 
* Radioautographs exposed 2 wk. 
$ Infected with approximately 8  X  106  L.  monocytogenes. Animals injected every 8 hr 
for 6 days with 0.34 #Ci of 3H-thymidine  per gram of body weight. First injection given 
at time of immunizing infection; lymph collected during first 24 hr after last injection. Pooled 
cells from three animals labeled in vitro with ~rI-5-uridine. 
§ Injected i.v. with 7 X  l0  s thoracic duct cells from infected donors. Cells collected 24-48 
hr after injection. 
hr interval from 24  to 48  hr  after injection, revealed that small lymphocytes 
were  the  only labeled cells which  had  recycled from  the blood in substantial 
numbers.  Evidently,  the  majority of  these  circulating  donor  cells had  been 
formed before  the  immunizing  infection,  for most  were  labeled only in  their 
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The  few  newly  formed  (DNA-labeled)  small  lymphocytes  which  did  re- 
circulate  from  the  blood  to  the  lymph  were  unable  to  influence  a  Listeria 
infection in a  second panel of normal recipients. Table III  shows that 5  X  108 
thoracic  duct  cells from  animals  which  had  been  adoptively  immunized  with 
TABLE III 
Protective Capacity of Thoracic Duct Cells from Actively Immunized  Donors and Adoptively 
Immunized Intermediate Hosts 
Donor immunization* 
No. cells  injected (10s/100 g body wt)  Logl0 protection:~ 
Total  DNA-labeled§ RNA-labeled§  Liver  Spleen 
Active  200  47  169  1.48  1.02 
50  12  43  0.98  0.61 
Adoptive  500  5  97  -- 0.14  -- 0.29 
* See footnotes to Table II regarding immunization and cell labeling. 
:~ Difference in viable Listeria in the livers and spleens of five normal rats and groups of 
five rats given thoracic duct cells.  Cells injected intravenously 1 hr after i.v. challenge with 
approximately  l0  T Listeria monocytogenes. Animals sacrificed 48  hr  after  challenge.  Using 
Duncan's multiple range test, all means were found  to be significantly different from each 
other at the P  <  0.01  level. 
§ Radioautographs exposed 2 wk. 
TABLE IV 
Circulation Dynamics of Thoracic Duct Cells  from Normal and Listeria-Infected Donors 
Donor status*  Thoracic duct cells 
Per cent lymphocytes labeled~; 
Large and medium  Small 
Normal  Donors  80.0  7.4 
Recipients§  < 0.2  0.9, 0.9 
Immune  Donors  88.8  17.8 
Recipients§  < 0.2  0.6, 0.8 
* Three normal  (Lewis  X  DA)F1 hybrid  rats  and  three  (Lewis  X  DA)F1 hybrid  rats 
infected with 9.3  X  l0  s Listeria monocytogenes. Animals injected every 8 hr for 6 days with 
0.34  /zCi of 3H-thymidine per  gram  of body weight.  First injection given at  time of im- 
munizing infection; lymph collected during first 24 hr after last injection. 
Radioautographs exposed 2 wk. 
§ Two rats injected i.v. with 7  X  10  s thoracic duct cells from labeled donors.  Cells col- 
lected 24-36 hr after injection. 
7  X  108 cells from Listeria-infected donors failed to inhibit the growth  of Lis- 
teria  in  liver  and  spleen.  By  comparison,  only  5  X  l0  T ceils  from  the  same 
Listeria-infected  rats  provided  substantial  protection  in  both  organs.  The  re- 
suits imply not only that the newly formed lymphocytes of infected rats fail to 
recirculate in large numbers from blood to lymph, but that the failure to recir- 
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Production  of Recirculating  Lymphocytes  in  Listeria-Infected  Rals.--In  the 
foregoing experiment, it was found that  a  few small lymphocytes generated 
during an acute Listeria  infection were able to recirculate. It is possible that 
these join the mass of long-lived small lymphocytes that are generated through- 
out life at a rate proportional to body growth  (12). It would be of interest to 
know whether the production of these cells is also influenced by infection. The 
delivery of newly formed, recirculating lymphocytes to the  thoracic ducts  of 
normal and Listeria-infected  rats was therefore studied. For this purpose,  the 
donor animals were injected repeatedly with 3H-thymidine (Table IV). Thoracic 
duct cells,  collected during  the first 24 hr  after the last  of 18 3H-thymidine 
injections,  were  injected  into  syngeneic  recipients,  precautions  again  being 
taken to minimize reutilization of radioactive material released from labeled 
donor cells.  Radioautographs prepared from the recipients' thoracic duct cells 
collected over a 12 hr period, 24-36 hr after injection, revealed that a portion 
of the small lymphocytes originally present in the donor inoculum had recycled 
from the blood (Table IV). But the number of labeled cells which followed this 
migration pathway was no greater in recipients of Listeria-immune  cells than 
it was in animals given labeled thoracic duct cells from normal, nonimmunized 
donors. 
DISCUSSION 
Host resistance against L.  monocytogenes rests  ultimately with  the macro- 
phage.  The fixed and  mobile macrophages  of Listeria-infected  mice undergo 
remarkable changes in structure and function which are expressed in an ability 
of the cells to inactivate ingested organisms more rapidly (13). The process of 
macrophage activation has not been defined, although it is clearly driven by an 
immunological event in  which  specifically committed lymphoid cells have  a 
crucial role (1). Results of the present investigation support this concept of a 
cell-mediated defense mechanism; they indicate that cells with the capacity to 
protect  normal  rats  against  listeriosis  are  lymphocytes,  and  that  they  are 
represented  among  the  cells  in  the  thoracic  duct  lymph  of Listeria-infected 
donors. 
The presence of the protective cells in central lymph identifies them as lym- 
phocytes, but does not establish the species to which they belong. Rat thoracic 
duct lymph contains three categories of lymphocytes: a heterogeneous group of 
large and medium cells and two groups of small lymphocytes which cannot be 
distinguished  in conventional histological preparations,  but which differ with 
respect to turnover rate, and possibly also with respect to origin and immuno- 
logical capacity (6). About  10%  of the  small  lymphocytes normally present 
in the lymph have a rapid turnover rate, while the remaining 90 % are produced 
more slowly (12). 
Marked  changes  occur in  the  cellular makeup  of  thoracic  duct  lymph  in D.  D.  McGREGOR,  F.  T.  KOSTER,  AND  G.  B.  MACKANESS  397 
response to antigenic stimulation (3, 14). Large and medium lymphocytes, and 
small lymphocytes of the kind which have a rapid turnover rate,  are released 
into the lymph in increased numbers. In the present investigation, it was found 
that the increase in newly formed lymphocytes is impressive during the first 
wk of a primary Listeria infection. On the 7th day, when the animal's thoracic 
duct cells are able to confer antimicrobial resistance upon normal recipients, 
the increase in newly formed small lymphocytes was approximately 10 times 
greater than the combined increase in large and medium lymphocytes. 
The newly formed lymphocytes (large, medium, and small) which are added 
to the lymph of Listeria-infected  rats include the specifically committed cells 
which  convey antimicrobial  resistance.  It  is  presumed  from  studies  in  the 
mouse  (2)  that  committed  lymphocytes  express  their  protective  capacity 
through their ability to influence the microbicidal properties of macrophages. 
The ability of committed lymphocytes from the  thoracic duct lymph of ac- 
tively immunized donors to confer immediate protection against  a  challenge 
infection implies that the activation process is rapid and that the committed 
cells are functionally mature at the time of transfer. 
A companion paper indicates that the lymph-borne cells which convey anti- 
microbial protection can move from the blood into an induced peritoneal exu- 
date (15). Although it is not yet known what happens  to them in the  absence 
of an inflammatory stimulus,  the current investigation indicates that they do 
not recycle to the  thoracic duct in sufficient numbers  to transmit  immunity 
through  an  intermediate  host.  This  failure  of  immunologically  committed 
cells to recirculate places  them in a  class  apart from the small lymphocytes 
normally resident  in  the  circulating  lymphocyte pool  (9),  and  points  to  a 
physiological difference between the cells which initiate and those which express 
immunological  reactivity.  Thus,  small  lymphocytes  which  can  initiate  an 
immunological response such as the graft-versus-host reaction have a potentially 
long  life-span,  recirculate  repeatedly from blood  to  lymph,  and  can  realize 
their  immunological  capability  after  passage  through  an  intermediate  host 
(McGregor, D. D., unpublished observations). 
Only a small fraction of the lymphocytes generated during a primary Listeria 
infection were able to circulate from blood to lymph. Their failure to transmit 
immunity  to  a  second panel  of normal  recipients indicates  that  specifically 
committed lymphocytes do not readily recirculate. It must be admitted, how- 
ever, that the stress of physical restraint and the high concentrations of thy- 
midine and uridine used to inhibit the reutilization of radioactive nucleosides 
in the present experiments could have influenced the capacity of this cell type 
to recirculate. 
Others  have  shown  that  recirculating  lymphocytes  are  generated  during 
the evolution of a  graft-versus-host  reaction (16)  and the hemolysin response 
to sheep erythrocytes (17)  in the mouse. It is  not known, however, whether 398  THE  MEDIATOR OF  CELLULAR 1-~MUNITY. I 
these newly formed cells are the effectors of immunity, carriers of immunologi- 
cal memory, or whether  they are antigen-sensitive  cells  that have a  potential 
but  as  yet unexpressed  immunological capacity.  If antigen-sensitive  ceils  are 
formed  mainly  in  the  thymus  (6,  18)  from which  some  antigens  are  largely 
excluded (19), their production might not be influenced by the antigenic stimu- 
lus provided by a systemic bacterial infection. The present observations provide 
some support for this  notion by showing that  the  appearance  of recirculating 
lymphocytes in the thoracic duct lymph of the rat is not significantly increased, 
and may even decline during a primary infection with L. monocytogenes. 
SUMMARY 
Thoracic duct cells from rats which have survived an infection with Listeria 
monocytogenes  can confer a  high level of antimicrobial resistance upon normal 
recipients. The cells which confer protection appear in the thoracic duct during 
the 1st wk of the immunizing infection, at a  time when newly formed lympho- 
cytes are  being  added  to the  lymph  in substantially  increased  numbers.  The 
protective cells differ in at least  two respects from the majority of small lym- 
phocytes in central  lymph: they have  a  rapid  turnover rate  and  a  short life- 
span  in the  circulation. 
Evidence  was  also  obtained  that  lymphopoiesis  affecting  the  long-lived 
small  lymphocyte,  which  belongs  to  the  recirculating  pool,  is  not  increased 
during an acute Listeria infection. 
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